SCHEMBL3575367

SCHEMBL3575367

Fc1ccc(-c2c(Cl)nnc(Cl)c2-c2c(F)cc(F)cc2F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TYMP P19971 1/20 0.36
RIPK2 O43353 1/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
BRAF P15056 1/20 0.35
KDR P35968 1/20 0.35
TNK2 Q07912 1/20 0.35
PTK6 Q13882 1/20 0.35
MINK1 Q8N4C8 1/20 0.35
KDM4E B2RXH2 1/20 0.35
DHODH Q02127 1/20 0.34
GRM5 P41594 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580504 0.91 NPC1 (0.42) NPC1RAB9ATP53SMN1; SMN2TSHR
SCHEMBL2354401 0.90 MEN1 (0.35) NPC1RAB9ATP53SMN1; SMN2TSHR
SCHEMBL3572546 0.87 L3MBTL1 (0.38) KDRKDM4EGABRA1GABRG2GABRB3
SCHEMBL3577089 0.87 CASP1 (0.39) NPC1RAB9AHSD17B10GABRA1GABRG2
SCHEMBL13843633 0.86 KDM4E (0.39) NPC1RAB9ATP53SMN1; SMN2TSHR
SCHEMBL3579765 0.86 NPC1 (0.35) NPC1RAB9A
SCHEMBL3585564 0.84 AHR (0.43) NPC1RAB9AKDM4ECASP1NOTUM
SCHEMBL3581885 0.83 NPC1 (0.44) NPC1RAB9ATP53TSHRHSD17B10
SCHEMBL1869939 0.82 RAB9A (0.36) NPC1RAB9ATP53SMN1; SMN2TSHR
SCHEMBL1873945 0.82 KMT2A (0.34) NPC1RAB9ASMN1; SMN2KDRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-01-28 US claimed
EP-2121628-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES Syngenta Participations AG (CH) 2009-11-25 EP claimed
WO-2008089934-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2008-07-31 WO claimed
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-01-28 US disclosed
EP-2121628-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES Syngenta Participations AG (CH) 2009-11-25 EP disclosed
WO-2008089934-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022526-A1 PYRIDAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES CYP4Z1, CYP1A2, CYP1A1 NPC1 3839/4885RAB9A 2942/4885TP53 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.